RIGL Stock Price History and Quote Analysis Insights for Investors
Rigel Pharmaceuticals, Inc.
Stock Price Today
Rigel Pharmaceuticals, Inc. (RIGL) stock declined over -0.53%, trading at $18.91 on NASDAQ, down from the previous close of $19.01. The stock opened at $19.02, fluctuating between $18.40 and $19.57 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is in phase III clinical trial for the treatment of warm autoimmune hemolytic anemia; phase III clinical trial for the treatment of hospitalized COVID-19 patients; and phase III clinical trial for the treatment of COVID-19. In addition, the company is developing R289, an oral interleukin receptor associated kinase 1/4 inhibitor, which is in phase I clinical trial for autoimmune, inflammatory, and hematology-oncology diseases; and R552, a receptor-interacting serine/threonine-protein kinase 1 inhibitor that has completed phase I clinical trial for autoimmune and inflammatory diseases. It has research and license agreements with AstraZeneca AB for the development and commercialization of R256, an inhaled JAK inhibitor; BerGenBio AS for the development and commercialization of AXL inhibitors in oncology; and Daiichi Sankyo to develop murine double minute 2 inhibitors for solid and hematological malignancies, as well as license and supply agreement with Kissei Pharmaceutical Co., Ltd. to develop and commercialize Fostamatinib. The company also has a license agreement and strategic collaboration with Eli Lilly and Company to co-develop and commercialize R552 for various indications, including autoimmune and inflammatory diseases, as well as other non-central nervous system (non-CNS) disease development candidates. Rigel Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in South San Francisco, California.
Company Information
| Employees | 147 |
| Beta | 0.95 |
| Sales or Revenue | $116.88M |
| 5Y Sales Change% | 1.422% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) stock price is $18.91 in the last trading session. During the trading session, RIGL stock reached the peak price of $19.57 while $18.40 was the lowest point it dropped to. The percentage change in RIGL stock occurred in the recent session was -0.53% while the dollar amount for the price change in RIGL stock was -$0.10.
The NASDAQ listed RIGL is part of Biotechnology industry that operates in the broader Healthcare sector. Rigel Pharmaceuticals, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Esteban S. Masuda
Executive Vice President of Research
Mr. Tarek Sallam
Vice President of Marketing
Dr. Wolfgang Dummer M.D., Ph.D.
Executive Vice President & Chief Medical Officer
Mr. Dean L. Schorno C.P.A.
Executive Vice President & Chief Financial Officer
Mr. Raul R. Rodriguez
Pres, Chief Executive Officer & Director
Mr. Dean L. Schorno CPA
Executive Vice President & Chief Financial Officer
Mr. Raymond J. Furey J.D.
Executive Vice President, Gen. Counsel & Corporation Sec.
Mr. David A. Santos
Executive Vice President & Chief Commercial Officer
Mr. Joseph Lasaga
Executive Vice President of Corporation Devel.
Ms. Julie Patel
Senior Vice President of HR
RIGL's closing price is 152.81% higher than its 52-week low of $7.48 where as its distance from 52-week high of $29.82 is -36.59%.
Number of RIGL employees currently stands at 147.
Official Website of RIGL is: https://www.rigel.com
RIGL could be contacted at phone 650 624 1100 and can also be accessed through its website. RIGL operates from 1180 Veterans Boulevard, South San Francisco, CA 94080, United States.
RIGL stock volume for the day was 189.49K shares. The average number of RIGL shares traded daily for last 3 months was 221.58K.
The market value of RIGL currently stands at $333.10M with its latest stock price at $18.91 and 17.62M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com